Biotech Values

[wallstarb]

I think that the real value in MNTA over time will not come from the copy cat biologics but rather their own proprietary compounds like m118

To get bogged down in the short term revenues would seem to be misguided as MNTA won't be a cash generating company once the competition comes in (it will again be back to cash flow negative) but focus on the compunds which will add to the Lovenox streams however small or large they may be in 3 or 4 years.